Objective to investigate the platelet inhibition ratio by thromboelastography (TEG) and its clinical impact in patients undergoing percutaneous coronary intervention (PCI).
Thromboelastography is not perfect but I think it will provide a more global measurement and in general needs to be clinically validated in terms of clinical trials to determine its value.
